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Renal artery stenosis (RAS) is commonly presented with hypertension and chronic
kidney disease. We report a rare case of RAS occurring in a 78-year-old man who
presented with nephrotic-range proteinuria. Renal biopsy on the left side was
performed, and results showed mesangiopathic glomerulonephritis, which was not
compatible with the cause of nephrotic-range proteinuria. Proteinuria was
decreased by angiotensin receptor blocker, but azotemia was aggravated. Therefore,
angiotensin receptor blocker was discontinued inevitably and thorough evaluation
for the possibility of RAS was performed. Computed tomography angiography
revealed signiﬁcant RAS on the left side and a renal artery stent was inserted. After
stenting, aortic dissection developed and progressed despite tight control of blood
pressure. After inserting another stent graft through the true lumen of the left renal
artery, the patient's renal function and proteinuria improved markedly.
Copyright © 2015. The Korean Society of Nephrology. Published by Elsevier. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Renal artery stenosis (RAS) is frequently associated with
hypertension and renal insufﬁciency [1]. Nephrotic-range
proteinuria is usually caused by primary or secondary
glomerular diseases associated with diabetes, drugs, malig-
nancy, infectious disease, or autoimmune disease [2]. Although
proteinuria caused by RAS has been reported in some cases, it is
uncommon to cause signiﬁcant heavy proteinuria [3,4]. During
recent decades, ongoing research has pursued treatment op-
tions for renovascular disease, focusing on the effectiveness of
medical therapy and endovascular intervention [5e9]. Previousrology, Department of
wan University School of
5-710, Korea.
ty of Nephrology. Published b
/4.0/).clinical studies showed that renal artery stenting did not confer
signiﬁcant beneﬁt over medical therapy with respect to pre-
serving kidney function and preventing adverse cardiovascular
events [5e8]. However, revascularization still plays a substan-
tial role in the treatment of RAS, depending on each patient’s
clinical characteristics.
We herein describe a 78-year-old manwith severe RAS who
presented with heavy proteinuria and renal insufﬁciency and
was treated successfully by angioplasty and repeated stenting.
Case report
A 78-year-old man known to have had hypertension for 5
yearswas admittedbecause of 2-monthhistoryof pitting edema
in lower extremities. He had taken diuretics (furosemide) for a
month, but still complained of edematous legs. He had been in
good health until 2 months ago and had not taken anyy Elsevier. This is an open access article under the CC BY-NC-ND license
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sure (BP)was125/70mmHgonadmissionwithamlodipine5mg
orally once a day after switching from telmisartan 40 mg orally
once a day about 2 weeks before admission. He did not show
abdominal bruits and other physical signs suggesting infection.
Laboratory evaluation showed serum creatinine (Cr) of 1.58mg/
dL, serum sodiumof 142mmol/L, serumpotassiumof 4.2mmol/
L, serum albumin of 3.8 g/dL, and total cholesterol of 192mg/dL.
Liver function proﬁles, uric acid, and serum electrolytes were
within normal range. The number of white blood cells and the
levels of C-reactive protein and erythrocyte sedimentation rate
werealsowithinnormal range.His spot urineprotein-to-Cr ratio
(PCR) and spot urine albumin-to-Cr ratio (ACR) were 4.51 mg/
mg and 3,943.8 mg/mg, respectively. Tests for hepatitis B surface
antigen, antibody to hepatitis C virus, antinuclear antibodies,
and antineutrophilic cytoplasmic antibodies were negative.
Renal ultrasonography showed right and left kidneys
measuring 9.8 and 8.3 cm in length, respectively, with slightly
increased cortical echogenicity. Percutaneous biopsy of the left
kidney revealed mesangiopathic glomerulonephritis (Fig. 1A),
with 30% of glomeruli showing global sclerosis. Immunoﬂuo-
rescence was negative, and electron microscopy was unre-
markable (Fig. 1B). Heavy proteinuria could not be explained by
the results of kidney biopsy. Small restrictions of the gamma
globulin region were found at the serum electrophoresis, and
an abnormal band was observed against anti-IgG and anti-
kappa from serum immunoﬁxation. However, bone marrow
biopsy showed no deﬁnite evidence of clonality in plasma cells.
A week after resuming angiotensin receptor blocker (ARB)
(losartan 50 mg orally once a day), spot urine PCR and ACR
decreased from 4.51 to 2.30 mg/mg and from 3,943.8 to 1,887.1
mg/mg, respectively. However, renal function signiﬁcantly
deteriorated (increase in serum Cr from 1.73 to 2.75 mg/dL).
ARB was discontinued because of rapidly progressive azotemia.
Considering the size discrepancy of both kidneys and pro-
gressive azotemia by ARB, RAS was suspected. Therefore, renal
artery computed tomography (CT) angiography and angiogram
of renal artery were performed. The results showed severe
stenosis of left main renal artery origin site (90%; Figs. 2AeB)
andmild luminal narrowing of proximal right main renal artery
(less than 30%). A stent was successfully inserted into the left
renal artery (Fig. 2C). However, focal aortic dissection devel-
oped right after the intervention.Figure 1. Features of the renal biopsy. (A) The glomeruli are mildly hypercellu
mildly increased (PAS, 400). (B) The glomerular basement membrane is sligh
mesangial matrix is slightly increased (transmission electron microscopy, 4,0
PAS, periodic acid-Schiff.Three days after renal artery stenting, the spot urine PCR and
ACR decreased from2.30 to 0.55mg/mg and from1,887.1 to 77.8
mg/mg, respectively. However, serum Cr level increased to 2.84
mg/dL. Aorta noncontrast CT showed acute intramural hema-
toma at descending and abdominal aorta and localized dissec-
tion at the distal segment of abdominal aorta. Conservative
management with tight control of BP was continued. Thor-
acoabdominal CT angiography taken 5 days later showed pro-
gression of the intramural hematoma of aorta. The diameter of
the aortawas increased, and the aortic dissection extended from
the origin of superior mesentery artery to right common iliac
artery. The progressed aortic dissection partially blocked the
entryof the stent originally inserted into left renal artery, but the
left kidney still received blood ﬂow from the true lumen of aorta
(Fig. 3). Three days later, angiography was performed again
because of persistent azotemia showing serum Cr higher than
2.0 mg/dL. Angiography showed that the entire oriﬁce of left
renal artery stent was in the false lumen because of progressed
aortic dissection, so the left kidney was not receiving any blood
ﬂow from the true lumen (Fig. 4A). Another stent graft insertion
into the original stent and balloon dilatation were therefore
performed on left renal artery, restoring blood ﬂow from the
true lumen of the aorta (Fig. 4B). After intervention, serum Cr
level decreased to1.76mg/dL, and thepatientwasdischargedon
aspirin and a b-blocker (atenolol). Spot urine PCR and ACR at
discharge were 0.27 mg/mg and 156.6 mg/mg, respectively.
He has had stable renal function with serum Cr around 1.50
mg/dL and minimal microalbuminuria, and well-controlled BP
was observed for more than 2 years after discharge.
Discussion
RAS is a common cause of curable hypertension and renal
insufﬁciency [1], but has not been mentioned as a major cause
of heavy proteinuria in previously reported reviews [2]. How-
ever, a few cases of nephrotic-range proteinuria in patients
with renovascular disease have been reported, usually resulting
from atherosclerosis, especially in the elderly [3,4,10,11]. In
some cases, massive proteinuria has been successfully treated
with angiotensin-converting enzyme inhibitors (ACE-i) or ARB
or by revascularization or removal of the affected kidney. In our
case, an elderly patient presented with nephrotic-range pro-
teinuria without typical signs of RAS, such as uncontrolledlar and show focal mesangial proliferation in PAS stain. Mesangial matrix is
tly irregular in contour with mild effacement of epithelial foot processes;
00).
Figure 2. Renal artery CT angiography and renal artery angiography. (A) Renal artery CT angiogram shows severe stenosis of the left main renal artery
origin site (90%; arrows). (B) Conventional angiogram of the renal artery demonstrates left renal artery stenosis (arrows). (C) A stent was successfully
inserted into the left renal artery. After angioplasty and stent insertion, blood ﬂow to the left renal artery was markedly improved. However, focal aortic
dissection (arrows) developed right after the intervention.
CT, computed tomography.
Hwang et al / RAS with nephrotic-range proteinuria 121hypertension. Therefore, several work-ups including kidney
biopsy and renal artery CT angiography were performed before
the ﬁnal diagnosis of RAS. Because the lesion of RAS was so
tight, aortic dissection developed as a complication after renal
artery stenting. Although we maintained appropriate conser-
vative treatment, including tight control of BP, aortic dissection
progressed, so we performed balloon angioplasty followed by
insertion of another stent graft into the left renal artery. After
interventions for left RAS, the patient's renal function andFigure 3. Thoracoabdominal aorta CT. Thoracoabdominal CT angiogram
taken 8 days after stent insertion shows dissection in the abdominal aorta
around the left renal artery (arrows). Some portion of the left renal artery
stent was found in the false lumen because of aortic dissection.
CT, computed tomography.proteinuria improved markedly. We believe this case is valu-
able as an instructive case that appropriate intervention can be
the treatment of choice for RAS presenting with nephrotic-
range proteinuria in elderly patients.
Although the mechanism of nephrotic-range proteinuria in
RAS remains unclear, increased glomerular membrane
permeability caused by the effect of angiotensin II on the
activation of the intrarenal renineangiotensin system is prob-
ably involved. Renin activity was high in RAS patients with
nephrotic-range proteinuria [3,4,12], and some cases showed
improvements of proteinuriawith ACE-i or ARB [3,10]. This case
could be evidence of proteinuria caused by activated ren-
nineangiotensin system because proteinuria was markedly
improved by ARB treatment and revascularization of RAS. ACE-i
and ARB are optimal antihypertensive choices for patients with
atherosclerotic renovascular disease, especially those with
coexisting coronary artery disease [13]. However, ACE-i and
ARB in patients with RAS can cause renal dysfunction; there-
fore, careful monitoring of renal function is required, especially
in patients with bilateral RAS [14].
Severe RAS usually leads to hyperﬁltration and kidney
ischemia, which may predispose an affected kidney to second-
ary forms of focal segmental glomerulosclerosis. In 1996,
Thadhani et al [15] reported 24 cases of focal segmental glo-
merulosclerosis in patients aged older than 50 years and iden-
tiﬁed 7 patients with renovascular disease and substantial
proteinuria. In our case, the pathologic ﬁnding of the left kidney
was not typical in RAS, but mesangiopathic glomerulonephritis
combined with RAS could cause the heavy proteinuria. And the
Figure 4. Aortography. (A) The left renal artery stent was found in the false lumen because of aortic dissection, the left kidney did not get blood ﬂow from
the true lumen of the aorta. (B) The stent graft was inserted into the left renal artery. After stent graft insertion, blood ﬂow from the true lumen of the aorta
was restored to the left renal artery. The arrow indicates mild luminal narrowing of the proximal right main renal artery (less than 30%).
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tell that RASwas themain cause of nephrotic-range proteinuria.
Many researchers have examined treatments for athero-
sclerotic RAS [6e8]. In previous randomized trials, intervention
including renal artery stenting was not superior to medical
treatment in the aspect of preserving kidney function and
controlling BP [6,7]. Recently, a randomized trial including 947
patients with RAS compared 2 types of treatment: medical
therapy plus renal artery stenting and medical therapy alone.
That trial found no signiﬁcant differences between the groups
in cardiovascular or renal events, including myocardial infarc-
tion, stroke, hospitalization for congestive heart failure, pro-
gressive renal insufﬁciency, and the need for renal replacement
therapy [8]. In a recent meta-analysis review, BP, renal function,
and cardiovascular events were compared between medical
therapy and revascularization, but analysis regarding protein-
uria was not included [5]. Although no solid evidence supports
that interventions for RAS are superior to medical treatment,
renal prognosis can be deﬁnitely improved by intervention in
some patients with RAS. In previously reported cases as well as
our patient, angioplasty and subsequent stenting in RAS pa-
tients with nephrotic-range proteinuria improved renal
outcome with an obvious decrease in proteinuria [11,12].
In conclusion, RAS should be considered in the differential
diagnosis of idiopathic nephrotic-range proteinuria, especially
in elderly patients. Revascularization needs to be considered for
the treatment of RAS with signiﬁcant proteinuria, and careful
monitoring for complications suchas aorticdissection isneeded.
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